0 followers
To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.
QuellTX
4 followers
Sutro Biopharma
3 followers
Active Motif
3 followers
FUJIFILM Diosynth Biotechnologies
16 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Phaidon Press
3 followers
Marshmallow
6 followers
London School of Economics and Political Science
7 followers
Eikon Therapeutics
3 followers
Kraken
6 followers
Explore companies